Market Capitalization of Glenmark Pharmaceuticals (GLENMARK)
As of Sept. 18, 2026, Glenmark Pharmaceuticals (GLENMARK) market capitalisation is ₹68270.02 Cr ($7.59B), with 27.89 Cr shares outstanding at a current price of ₹2447.40 on NSE, ranking 161 out of 5367 companies by market cap in our screener. Glenmark Pharmaceuticals operates in the Healthcare sector and is classified as a Large Cap stock. For live price, earnings and the complete company profile, see GLENMARK share price screener.
Market Cap History of Glenmark Pharmaceuticals (Last 10 Years)
GLENMARK market capitalisation from year-end NSE closing prices over the last 10 years. Explore GLENMARK Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
End of Year Market Cap History — Glenmark Pharmaceuticals
GLENMARK year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. View GLENMARK 52-week chart for the annual high/low range and current price position.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹68270.02 Cr
$7.59B USD
|
₹2447.40 | NSE | +20.25% |
| 2025 |
₹56771.74 Cr
$6.31B USD
|
₹2035.20 | NSE | +26.48% |
| 2024 |
₹44885.71 Cr
$4.99B USD
|
₹1609.10 | NSE | +88.43% |
| 2023 |
₹23820.86 Cr
$2.65B USD
|
₹853.95 | NSE | +101.33% |
| 2022 |
₹11831.63 Cr
$1.31B USD
|
₹424.15 | NSE | -19.75% |
| 2021 |
₹14743.86 Cr
$1.64B USD
|
₹528.55 | NSE | +7.10% |
| 2020 |
₹13766.14 Cr
$1.53B USD
|
₹493.50 | NSE | +42.03% |
| 2019 |
₹9692.09 Cr
$1.08B USD
|
₹347.45 | NSE | -49.87% |
| 2018 |
₹19332.57 Cr
$2.15B USD
|
₹693.05 | NSE | +16.53% |
| 2017 |
₹16590.50 Cr
$1.84B USD
|
₹594.75 | NSE | -33.06% |
| 2016 |
₹24783.24 Cr
$2.75B USD
|
₹888.45 | NSE | -3.63% |
| 2015 |
₹25716.32 Cr
$2.86B USD
|
₹921.90 | NSE | +19.70% |
| 2014 |
₹21484.67 Cr
$2.39B USD
|
₹770.20 | NSE | +44.27% |
| 2013 |
₹14891.70 Cr
$1.65B USD
|
₹533.85 | NSE | +1.00% |
| 2012 |
₹14743.86 Cr
$1.64B USD
|
₹528.55 | NSE | +80.05% |
| 2011 |
₹8188.55 Cr
$909.84M USD
|
₹293.55 | NSE | -18.93% |
| 2010 |
₹10100.75 Cr
$1.12B USD
|
₹362.10 | NSE | +31.27% |
| 2009 |
₹7694.81 Cr
$854.98M USD
|
₹275.85 | NSE | -6.84% |
| 2008 |
₹8259.68 Cr
$917.74M USD
|
₹296.10 | NSE | -50.32% |
| 2007 |
₹16625.37 Cr
$1.85B USD
|
₹596.00 | NSE | +97.78% |
| 2006 |
₹8406.13 Cr
$934.01M USD
|
₹301.35 | NSE | +92.21% |
| 2005 |
₹4373.37 Cr
$485.93M USD
|
₹156.78 | NSE | +29.34% |
| 2004 |
₹3381.42 Cr
$375.71M USD
|
₹121.22 | NSE | +238.89% |
| 2003 |
₹997.80 Cr
$110.87M USD
|
₹35.77 | NSE | - |